Last Updated: August 9, 2026

Breckenridge Pharm Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for BRECKENRIDGE PHARM

BRECKENRIDGE PHARM has five approved drugs.

There is one tentative approval on BRECKENRIDGE PHARM drugs.

Summary for Breckenridge Pharm

US Patents:	0
Tradenames:	5
Ingredients:	5
NDAs:	5
Patent Litigation for Breckenridge Pharm:	See patent lawsuits for Breckenridge Pharm
PTAB Cases with Breckenridge Pharm as petitioner:	See PTAB cases with Breckenridge Pharm as petitioner

Drugs and US Patents for Breckenridge Pharm

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Breckenridge Pharm	OXCARBAZEPINE	oxcarbazepine	TABLET;ORAL	078069-001	Jan 11, 2008	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Breckenridge Pharm	POLYETHYLENE GLYCOL 3350	polyethylene glycol 3350	FOR SOLUTION;ORAL	077736-001	May 26, 2006		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
Breckenridge Pharm	METHSCOPOLAMINE BROMIDE	methscopolamine bromide	TABLET;ORAL	040642-001	Dec 6, 2011	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Breckenridge Pharm	ESTRADIOL AND NORETHINDRONE ACETATE	estradiol; norethindrone acetate	TABLET;ORAL	078324-001	Apr 17, 2008	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Breckenridge Pharm	METHSCOPOLAMINE BROMIDE	methscopolamine bromide	TABLET;ORAL	040642-002	Dec 6, 2011	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Breckenridge Pharm	TERBINAFINE HYDROCHLORIDE	terbinafine hydrochloride	TABLET;ORAL	077714-001	Jun 4, 2010		DISCN	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.